Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005–2017
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Vaccine hesitancy is among the top ten threats to global health, and access to precise data on adverse events following immunization (AEFIs) is imperative to alleviate public concerns surrounding vaccines. This study aimed to present the overall trends of AEFIs reported in South Korea. Materials and Methods: We evaluated the trends of AEFIs using the Korea Institute of Drug Safety & Risk Management-Korea Adverse Event Reporting System database between January 2005 and December 2017. AEFIs were classified into five categories to evaluate associations between vaccines and AEFIs through a case-non-case study: neurologic reactions, general systemic reactions, local reactions, allergic reactions, and others. Results: Among 54378 reported adverse events (AEs) associated with all vaccines approved in South Korea, more than half (56.7%) occurred following influenza vaccination, followed by the pneumococcal (11.6%) and Bacillus Calmette-Guérin (BCG) vaccines (5.0%). After immunization with most vaccines, general systemic reactions were most common, followed by local and neurologic reactions. Adjusted reporting odds ratios were calculated for all neurologic, general, local, and allergic reactions: of all vaccines, rotavirus [neurologic 2.43, 95% confidence interval (CI), 2.25–2.62], BCG (general; 2.20, 95% CI, 1.91–2.53), BCG (local; 3.15, 95% CI, 2.69–3.68), and Japanese encephalitis (allergic 2.38, 95% CI, 1.98–2.87) vaccines showed the highest values. Conclusion: The majority of reported AEFIs were non-serious and mostly general systemic reactions. Sufficient knowledge on the AEFIs would secure public confidence on the safety of vaccines, thereby reducing public health burden from vaccine-preventable diseases.
Abstract
Purpose: Vaccine hesitancy is among the top ten threats to global health, and access to precise data on adverse events following immunization (AEFIs) is imperative to alleviate public concerns surrounding vaccines. This study aimed to present the overall trends of AEFIs reported in South Korea. Materials and Methods: We evaluated the trends of AEFIs using the Korea Institute of Drug Safety & Risk Management-Korea Adverse Event Reporting System database between January 2005 and December 2017. AEFIs were classified into five categories to evaluate associations between vaccines and AEFIs through a case-non-case study: neurologic reactions, general systemic reactions, local reactions, allergic reactions, and others. Results: Among 54378 reported adverse events (AEs) associated with all vaccines approved in South Korea, more than half (56.7%) occurred following influenza vaccination, followed by the pneumococcal (11.6%) and Bacillus Calmette-Guérin (BCG) vaccines (5.0%). After immunization with most vaccines, general systemic reactions were most common, followed by local and neurologic reactions. Adjusted reporting odds ratios were calculated for all neurologic, general, local, and allergic reactions: of all vaccines, rotavirus [neurologic 2.43, 95% confidence interval (CI), 2.25–2.62], BCG (general; 2.20, 95% CI, 1.91–2.53), BCG (local; 3.15, 95% CI, 2.69–3.68), and Japanese encephalitis (allergic 2.38, 95% CI, 1.98–2.87) vaccines showed the highest values. Conclusion: The majority of reported AEFIs were non-serious and mostly general systemic reactions. Sufficient knowledge on the AEFIs would secure public confidence on the safety of vaccines, thereby reducing public health burden from vaccine-preventable diseases.
참고문헌 (28)
- "Ten threats to global health in 2019"[URL]
- Dubé E, "Vaccine hesitancy : an overview", Hum Vaccin Immunother, 9, pp.1763~1773 (2013)
- Zhou W, "Surveillance for safety after immunization : Vaccine Adverse Event Reporting System(VAERS)--United States, 1991-2001", MMWR Surveill Summ, 52, pp.1~24 (2003)
- Dey A, "Surveillance of adverse events following immunisation in Australia annual report", Commun Dis Intell, 43 (2019)
- Schumacher Z, "Surveillance for adverse events following immunization(AEFI)in Switzerland--1991-2001", Vaccine, 28, pp.4059~4064 (2010)
- Sato APS, "Use of electronic immunization registry in the surveillance of adverse events following immunization", Rev Saude Publica, 52, pp.4~ (2018)
- Rasmussen SA, "Vaccines and pregnancy : past, present, and future", Semin Fetal Neonatal Med, 19, pp.161~169 (2014)
- Moro PL, "Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System(VAERS), 1990 to 2014", Birth Defects Res, 109, pp.1057~1062 (2017)
- Fulton TR, "A systematic review of adverse events following immunization during pregnancy and the newborn period", Vaccine, 33, pp.6453~6465 (2015)
- Cassidy C, "Adverse event following immunization surveillance systems for pregnant women and their infants : a systematic review", Pharmacoepidemiol Drug Saf, 24, pp.361~367 (2015)
- Choe YJ, "Management of vaccine safety in Korea", Clin Exp Vaccine Res, 2, pp.40~45 (2013)
- 차혜경, "의약품부작용보고시스템(KAERS)을 활용한 예방접종 이상반응 분석", 한국웰니스학회지, 11(3), pp.459~470 (2016), 한국웰니스학회[DOI]
- "Guideline for use of Korea Adverse Event Reporting System Database" (2019)[URL]
- "Vaccine Recommendations and Guidelines of the ACIP" (2019)[URL]
- Faillie JL, "Case-non-case studies : principle, methods, bias and interpretation", Therapie, 74, pp.225~232 (2019)
- Wilson AM, "Application of data mining techniques in pharmacovigilance", Br J Clin Pharmacol, 57, pp.127~134 (2004)
- 윤재원, "The Korean Influenza National Immunization Program: History and Present Status", Infection and Chemotherapy, 49(4), pp.247~253 (2017), 대한감염학회
- "Vaccine Information Statements" (2019)[URL]
- 김재홍, "Bacille Calmette-Guérin (BCG) 백신 접종 후 림프절염의 발생 빈도", Pediatric Infection and Vaccine, 23(1), pp.54~61 (2016), 대한소아감염학회
- Venkataraman A, "Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions", Vaccine, 33, pp.5470~5474 (2015)
- 안상완, "한국, 일본 대만에서의 의약품 부작용 피해구제 제도 현황 조사", 약 학 회 지, 63(4), pp.214~220 (2019), 대한약학회[DOI]
- 김민경, "Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea", Clinical and Experimental Vaccine Research, 6(2), pp.146~155 (2017), 대한백신학회[DOI]
- Plesner AM, "Allergic reactions to Japanese encephalitis vaccine", Immunol Allergy Clin North Am, 23, pp.665~697 (2003)
- Walker WL, "Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016", Vaccine, 36, pp.4369~4374 (2018)
- McCallum AD, "Allergy to IXIARO and BIKEN Japanese encephalitis vaccines", J Travel Med, 20, pp.60~62 (2013)
- Scheller NM, "Quadrivalent HPV vaccination and the risk of adverse pregnancy outcomes", N Engl J Med, 376, pp.1223~1233 (2017)
- "Guiding Principles for Development of ACIP Recommendations for Vaccination during Pregnancy and Breastfeeding" (2008)[URL]
- "National Immunization Program for pediatrics in Korea" (2019)[URL]